What is the current stock price of Cyteir Therapeutics, Inc. (CYT)?

As of the latest market data, Cyteir Therapeutics, Inc. (CYT) is trading at $3.02. The stock has seen a loss of -2.27% today.

Does Cyteir Therapeutics, Inc. (CYT) pay a dividend?

Based on current data, Cyteir Therapeutics, Inc. does not have a confirmed active dividend policy.

What is the market cap of Cyteir Therapeutics, Inc.?

The current market capitalization of Cyteir Therapeutics, Inc. (CYT) is approximately unavailable.

CYT

Cyteir Therapeutics, Inc.·Healthcare

3.02

2.265%(−0.07)

Market Closed

Last Updated: — ET

52W L: $1.6552W H: $3.19

Company Profile

Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company is also developing CYT-1853, which is in preclinical trials for solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-06-18

Beta

0.10

Websitecyteir.com↗